Erratum to "t(8;21)(q22;q22) Translocation Involving AML1 and ETO in B Lymophoblastic Leukemia" [Hum Pathol 2010, 2:286-292] (DOI:10.1016/j.humpath.2009.08.004);t(8;21)(q22;q22) Translocation involving AML1 and ETO in B lymophoblastic leukemia

Human Pathology

Volumn 41, Issue 2, 2010, Pages 286-292

  Wang, Huan You ^a   Tirado, Carlos A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

B lymphoblastic leukemia; Fluorescence in situ hybridization; t(8; 21)(q22; q22)

Indexed keywords

CALCITONIN; CALCIUM; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; HEMOGLOBIN; HYBRID PROTEIN; METHOTREXATE; PAMIDRONIC ACID; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX1T1; UNCLASSIFIED DRUG; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BLOOD; BLOOD SMEAR; BONE MARROW BIOPSY; CALCIUM BLOOD LEVEL; CANCER RELAPSE; CASE REPORT; CHROMOSOME 21; CHROMOSOME 8; CHROMOSOME ANALYSIS; CHROMOSOME T(8;21)(Q22;Q22); CHROMOSOME TRANSLOCATION; CYTOCHEMISTRY; DYSPNEA; EPISTAXIS; ESCHERICHIA COLI INFECTION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GINGIVA BLEEDING; HEMOGLOBIN BLOOD LEVEL; HOSPITAL READMISSION; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; IMMUNOPHENOTYPING; INTERPHASE; LEUKOCYTE DIFFERENTIAL COUNT; LUNG EDEMA; METAPHASE; MORPHOLOGICAL TRAIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; SIGNAL TRANSDUCTION; THROMBOCYTE COUNT; TREATMENT OUTCOME; WASTING SYNDROME;

EID: 73749085800     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2010.02.005     Document Type: Erratum

References (20)

1. Downing J.R., and Shannon K.M. Acute leukemia: a pediatric perspective. Cancer Cell 2 (2002) 437-445
2. Downing J.R., and Harrison C.J. Cytogenetics of pediatric and adolescent acute lymphoblastic leukemia. Br J Haematol 144 (2009) 147-156
3. Caligiuri M.A., Strout M.P., and Gilliland D.G. Molecular biology of acute myeloid leukemia. Semin Oncol 24 (1997) 32-44
4. Amare P.S., Pais A., Nair C., Banavali S., and Advani S.H. Translocation (8;20), a variant of t(8;21), in T-acute lymphoblastic leukemia: a first report. Cancer Genet Cytogenet 145 (2003) 88-90
5. In: Shaffer L.G., and Tommerup N. (Eds). ISCN: An International System for Human Cytogenetics Nomenclature (2005), S. Karger, Basel
6. Vysis LSI AML1/ETO Dual Color, Dual Fusion Translocation Probe. http://international.abbottmolecular.com/LSIAML1ETODualColorDualFusionTranslocationProbe_5950.aspx
7. Erickson P., Gao J., Chang K.S., et al. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene,runt. Blood 80 (1992) 1825-1831
8. Peterson L.F., Boyapati A., Ahn E.Y., et al. Acute myeloid leukemia with the 8q22;21q22 translocation: secondary mutational events and alternative t(8;21) transcripts. Blood 110 (2007) 799-805
9. Okuda T., van Deursen J., Hiebert S.W., Grosveld G., and Downing J.G. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84 (1996) 321-330
10. Miyamoto T., Nagafuji K., Akashi K., et al. Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia. Blood 87 (1996) 4789-4796
11. Miyamoto T., Weissman I.L., and Akashi K. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc Natl Acad Sci USA 97 (2000) 7521-7526
12. Mitelman F. Mitelman database of chromosome aberrations in cancer (2005). http://cgap.nci.gov/Chromoosmes/Mitelman
13. Alfaro R., Perez-Dranero A., Duran M.A., Besalduch J., Rosell J., and Bernues M. dup(1)(q21q32) as a sole cytogenetic event is associated to a leukemic transformation in myelodysplastic syndromes. Leuk Res 32 (2008) 159-161
14. Bacher U., Schnittger S., Gruneisen A., Haferlach T., Kern W., and Haferlach C. Inverted duplication dup(1)(q32q21) as sole aberration in lymphoid and myeloid malignancies. Cancer Genet Cytogenet 188 (2009) 108-111
15. Dohner H., Arthur D.C., Ball E.D., et al. Trisomy 13: a new recurring chromosome abnormality in acute leukemia. Blood 76 (1990) 1614-1621
16. Dicker F., Haferlach C., Kern W., Haferlach T., and Schnittger S. Trisomy 13 is strongly associated with AML1/RUNX1 mutations and increased FLT3 expression in acute myeloid leukemia. Blood 110 (2007) 1308-1316
17. Kuchenbauer F., Schnittger S., Look T., et al. Identification of additional cytogenetic and molecular genetic abnormalities in acute myeloid leukemia with t(8;21)/AML-ETO. Br J Heamatol 134 (2006) 616-619
18. Goemans B.F., Zwaan C.h.M., Miller M., et al. Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia. Leukemia 19 (2005) 1536-1542
19. Paschka P., Marcucci G., Ruppert A.S., et al. Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): A Cancer and Leukemia Group B Study. J Clin Oncol 24 (2006) 3904-3911
20. Rege K., Swansbury G.J., Atra A.A., et al. Disease features in acute myeloid leukemia with t(8;21)(q22;q22). Influence of age, secondary karyotype abnormalities, CD19 status, and extramedullary leukemia on survival. Leuk Lymphoma 40 (2000) 67-77